Literature DB >> 23707954

Prometaphase arrest-dependent phosphorylation of Bcl-2 family proteins and activation of mitochondrial apoptotic pathway are associated with 17α-estradiol-induced apoptosis in human Jurkat T cells.

Cho Rong Han1, Do Youn Jun, Yoon Hee Kim, Ji Young Lee, Young Ho Kim.   

Abstract

In Jurkat T cell clone (JT/Neo), G2/M arrest, apoptotic sub-G1 peak, mitochondrial membrane potential (Δψm) loss, and TUNEL-positive DNA fragmentation were induced following exposure to 17α-estradiol (17α-E2), whereas none of these events (except for G2/M arrest) were induced in Jurkat cells overexpressing Bcl-2 (JT/Bcl-2). Under these conditions, phosphorylation at Thr161 and dephosphorylation at Tyr15 of Cdk1, upregulation of cyclin B1 level, histone H1 phosphorylation, Cdc25C phosphorylation at Thr-48, Bcl-2 phosphorylation at Thr-56 and Ser-70, Mcl-1 phosphorylation, and Bim phosphorylation were detected in the presence of Bcl-2 overexpression. However, the 17α-E2-induced upregulation of Bak levels, activation of Bak, activation of caspase-3, and PARP degradation were abrogated by Bcl-2 overexpression. In the presence of the G1/S blocking agent hydroxyurea, 17α-E2 failed to induce G2/M arrest and all apoptotic events including Cdk1 activation and phosphorylation of Bcl-2, Mcl-1 and Bim. The 17α-E2-induced phosphorylation of Bcl-2 family proteins and mitochondrial apoptotic events were suppressed by a Cdk1 inhibitor but not by aurora A and aurora B kinase inhibitors. Immunofluorescence microscopic analysis showed that an aberrant bipolar microtubule array, incomplete chromosome congression at the metaphase plate, and prometaphase arrest, which was reversible, were the underlying factors for 17α-E2-induced mitotic arrest. The in vitro microtubule polymerization assay showed that 17α-E2 could directly inhibit microtubule formation. These results show that the apoptogenic activity of 17α-E2 was due to the impaired mitotic spindle assembly causing prometaphase arrest and prolonged Cdk1 activation, the phosphorylation of Bcl-2, Mcl-1 and Bim, and the activation of Bak and mitochondria-dependent caspase cascade.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  17α-Estradiol; Mitochondrial apoptosis; Phosphorylation of Bcl-2 family protein; Prolonged Cdk1 activation; Prometaphase arrest

Mesh:

Substances:

Year:  2013        PMID: 23707954     DOI: 10.1016/j.bbamcr.2013.05.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Identification, characterization and functional analysis of anti-apoptotic protein BCL-2-like gene from pufferfish, Takifugu obscurus, responding to bacterial challenge.

Authors:  Chang-Hong Cheng; Fang-Fang Yang; Shao-An Liao; Yu-Tao Miao; Chao-Xia Ye; An-Li Wang; Jin-Chang Liu; Li-Wei Liu
Journal:  Fish Physiol Biochem       Date:  2015-05-12       Impact factor: 2.794

2.  Cis-trimethoxy resveratrol induces intrinsic apoptosis via prometaphase arrest and prolonged CDK1 activation pathway in human Jurkat T cells.

Authors:  Chae Eun Kim; Do Youn Jun; Jong-Sik Kim; Young Ho Kim
Journal:  Oncotarget       Date:  2017-12-22

3.  Ectopic overexpression of LAPTM5 results in lysosomal targeting and induces Mcl-1 down-regulation, Bak activation, and mitochondria-dependent apoptosis in human HeLa cells.

Authors:  Do Youn Jun; Hyejin Kim; Won Young Jang; Ji Young Lee; Kiyoshi Fukui; Young Ho Kim
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

4.  Cytoprotective effect of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) is mediated by the inhibition of BAK-dependent mitochondrial apoptosis pathway.

Authors:  Do Youn Jun; Won Young Jang; Ki Yun Kim; Mi Hee Woo; Young Ho Kim
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

5.  Enhancement of Quercetin-Induced Apoptosis by Cotreatment with Autophagy Inhibitor Is Associated with Augmentation of BAK-Dependent Mitochondrial Pathway in Jurkat T Cells.

Authors:  Eun Ji Ha; Ki Yun Kim; Chae Eun Kim; Do Youn Jun; Young Ho Kim
Journal:  Oxid Med Cell Longev       Date:  2019-11-15       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.